Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

LINCOLN PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -7.7120.295.8813.6121.24

What is the latest Core EBITDA Growth ratio of LINCOLN PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of LINCOLN PHARMACEUTICALS is -7.71 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-7.71
Mar202420.29
Mar20235.88
Mar202213.61
Mar202121.24

How is Core EBITDA Growth of LINCOLN PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -7.71
Negative
Mar2024 20.29
245.07
Mar2023 5.88
-56.80
Mar2022 13.61
-35.92
Mar2021 21.24 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,147.3 Cr -2.1% -7.2% 11.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,326.0 Cr -5.7% -3.3% -2.1% Stock Analytics
DIVIS LABORATORIES ₹155,282.0 Cr -3.1% -9.3% 0% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,043.0 Cr -6.1% -8.3% 23.7% Stock Analytics
DR REDDYS LABORATORIES ₹99,854.2 Cr -5.1% -6% 4.8% Stock Analytics
CIPLA ₹97,115.7 Cr -3.3% -11.2% -19.5% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-2.1%

-7.2%

11.5%

SENSEX

-1.6%

-8.8%

-4.1%


You may also like the below Video Courses